文献速递头颈外科

癌症家族史与头颈癌生存关联研究

Family history of cancer and head and neck cancer survival.
PubMed 文献 · Laryngoscope · 2017-03-07

研究纳入643例原发性头颈鳞癌患者,随访至多5年,采用Cox比例风险模型分析一级亲属癌症家族史与疾病特异性生存的关联。多变量调整后,家族史与头颈鳞癌死亡呈非显著负相关(HR=0.88,95%CI 0.57-1.35);在诊断时同时饮酒和吸烟的患者中关联更强且具统计学显著性(HR=0.46,95%CI 0.22-0.97),而不饮酒不吸烟者中无关联(HR=1.14,95%CI 0.68-1.91;交互作用P=0.046)。作者认为家族史可能与他汀类使用者的疾病特异性生存改善相关,需更大规模研究证实。

要点

  • 643例头颈鳞癌患者中,一级亲属癌症家族史与疾病特异性生存呈非显著负相关(HR=0.88,95%CI 0.57-1.35)。
  • 诊断时同时饮酒和吸烟者中,家族史与死亡风险降低显著相关(HR=0.46,95%CI 0.22-0.97)。
  • 不饮酒不吸烟者中未见关联(HR=1.14,95%CI 0.68-1.91),交互作用P=0.046。

核心结论

  • 癌症家族史可能与同时使用烟草和酒精的头颈鳞癌患者的疾病特异性生存改善相关。
  • 需额外大规模研究,尤其纳入非白人和女性人群,以证实或反驳该关联并阐明潜在遗传因素。

研究设计与样本

  • 研究为队列研究,通过密歇根大学研究卓越专项项目招募643例原发性头颈鳞癌患者,随访至多5年。
  • 采集个人及家族癌症史、人口学信息和行为习惯,采用Cox比例风险模型估计一级亲属癌症家族史与疾病特异性生存的关联。

主要发现

  • 多变量调整后,家族史与头颈鳞癌死亡呈非显著负相关(HR=0.88,95%CI 0.57-1.35)。
  • 诊断时同时饮酒和吸烟的患者中,家族史与死亡风险降低显著相关(HR=0.46,95%CI 0.22-0.97)。
  • 诊断时不同时饮酒和吸烟的参与者中未观察到关联(HR=1.14,95%CI 0.68-1.91;交互作用P=0.046)。

关键数值与推荐

  • 一级亲属癌症家族史与疾病特异性生存的关联:总体HR=0.88(95%CI 0.57-1.35)。
  • 同时饮酒和吸烟者中HR=0.46(95%CI 0.22-0.97);不同时饮酒和吸烟者中HR=1.14(95%CI 0.68-1.91);交互作用P=0.046。
  • 证据等级为2b。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需额外大规模研究,尤其纳入非白人和女性人群,以证实或反驳该关联并阐明潜在遗传因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with a family history of cancer may be genetically predisposed to carcinogenesis. This could affect risk of recurrence, second primary tumors, and overall outcomes after treatment of a primary cancer. We evaluated the association between family history of cancer and disease-specific survival in a cohort of patients with primary head and neck squamous carcinoma (HNSCC). STUDY DESIGN: Six hundred and forty-three incident HNSCC patients recruited through the University of Michigan Specialized Program of Research Excellence were followed for up to 5 years for survival. Participants were interviewed about personal and family cancer history, demographic information, and behavioral habits. METHODS: Cox proportional hazards models were used to estimate the association between family history of cancer in a first-degree relative and disease-specific survival. RESULTS: After multivariable adjustment, we found a nonsignificant inverse association between family history and HNSCC mortality (hazard ratio [HR] = 0.88, 95% confidence interval [CI] 0.57-1.35). This association was stronger and statistically significant among patients who currently both drank alcohol and smoked cigarettes at diagnosis (HR = 0.46, 95% CI = 0.22-0.97); no association was observed among participants who did not both drink and smoke at the time of diagnosis (HR = 1.14, 95% CI = 0.68-1.91; p-interaction = 0.046). CONCLUSION: Results from this study suggest that having a family history of cancer may be associated with improved disease-specific survival in patients who use tobacco and alcohol. Additional large studies, particularly in populations including nonwhites and women, are needed to confirm or refute the association and to elucidate the genetic factors that may underlie this potential association. LEVEL OF EVIDENCE: 2b. Laryngoscope, 127:1816-1820, 2017.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Getz KR, Rozek LS, Peterson LA, et al. Family history of cancer and head and neck cancer survival. Laryngoscope. 2017. PMID: 28266024. doi:10.1002/lary.26524

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。